Use of proton pump inhibitors and risk of osteoporosis-related fractures
- Clinical briefs. // New Zealand Doctor;9/24/2008, p23
This section offers medical news briefs. U.S. researchers have successfully grown blood types A, B, O and Rh-positive and Rh-negative blood from human embryonic cells. A Finnish research suggests that the use of steroids for children could be reduced as soon as their asthma has been controlled....
- A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate. Lee, Joongyub; Youn, KyungEun; Choi, Nam-Kyong; Lee, Jin-Ho; Kang, DongYoon; Song, Hong-Ji; Park, Byung-Joo // Journal of Gastroenterology;Sep2013, Vol. 48 Issue 9, p1016
Background: Studies on the risk of osteoporotic fractures related to the use of proton pump inhibitors (PPIs) have been inconsistent. One recent cohort study reported that there was an interaction between PPIs and bisphosphonates (BPs). Thus we performed a case-control study aimed at evaluating...
- PPIs linked to osteoporosis. // Practice Nurse;1/12/2007, Vol. 33 Issue 1, p6
The article reports that long-term use of proton pump inhibitors (PPI) for the treatment of stomach acid problems may increase the risk of hip fracture. Researchers from the University of Pennsylvania School of Medicine found that patients taking PPI for more than a year had a 44% greater risk...
- Long-term use of proton pump inhibitors increased bone fracture risk. // Endocrine Today;10/25/2008, Vol. 6 Issue 19, p20
The article discusses research which revealed the association of long-term use of proton pump inhibitors with increased risk for osteoporosis-related fractures.
- GI medicines linked to bone fractures. // Gastrointestinal Nursing;Jun2012, Vol. 10 Issue 5, p7
The article reports that the Medicines and Healthcare products Regulatory Agency (MHRA), has issued a warning about long-term use of proton pump inhibitors (PPIs) and gastrointestinal (GI) medicines that are linked to bone fractures.
- PPIs increase osteoporotic. // Australian Journal of Pharmacy;May2009, Vol. 90 Issue 1068, p76
The article reports on the study that determines the relation between duration of exposure to proton pump inhibitors (PPI) and fractures.
- Proton pump inhibitors: balancing the benefits and potential fracture risks. Richards, J. Brent; Goltzman, David // CMAJ: Canadian Medical Association Journal;8/12/2008, Vol. 179 Issue 4, p306
The article discusses a report published within the issue which suggests that the use of proton pump inhibitors is associated with potential risk of an osteoporotic fracture.
- Chronic use of PPIs associated with increased risk of hip fracture. Thomas, Jack // Australian Journal of Pharmacy;Jun2012, Vol. 93 Issue 1105, p84
The article informs about cohort analysis in order to examine the association between chronic use of proton pump inhibitors (PPIs) and increased risk of hip fracture especially among women with smoking history in Australia. It mentions several PPIS available in Australia which includes...
- The Relationship Between Proton Pump Inhibitor Adherence and Fracture Risk in the Elderly. Ding, Jian; Heller, Debra; Ahern, Frank; Brown, Theresa // Calcified Tissue International;Jun2014, Vol. 94 Issue 6, p597
Studies suggest that long-term use of proton pump inhibitors (PPIs) may be associated with an increased risk of fracture. However, the role of medication adherence in this association is not fully understood. A retrospective cohort study was conducted to examine the relationship between PPI...